Anupama Reddy

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• IRIS-RCC: Individual RNA-seq Intrinsic Subtyping for Renal Cell Carcinoma

  Zenodo (CERN European Organization for Nuclear Research) · 2026-06-23

• IRIS-RCC: Individual RNA-seq Intrinsic Subtyping for Renal Cell Carcinoma

  Zenodo (CERN European Organization for Nuclear Research) · 2026-06-23

• Abstract A034: HIF-2-mediated gene expression is highest in metastatic and cluster-exclude clear cell renal cell carcinoma tumors

  Cancer Research · 2026-03-13

• Abstract A001: Mitochondrial potential as a biomarker of T cell fitness and function in cancer immunotherapy

  Cancer Research · 2026-03-13

• 2591O Efficacy of cabozantinib and nivolumab in cluster 1/2 metastatic clear cell renal cell carcinoma: Results from OPTIC RCC, a phase II trial of a novel RNAseq-based biomarker

  Annals of Oncology · 2025-09-01 · 7 citations

• 2596MO Phase Ib/II trial of ipilimumab, nivolumab, and ciforadenant (adenosine A2a receptor antagonist) in first-line advanced renal cell carcinoma (RCC), a kidney cancer research consortium study

  Annals of Oncology · 2025-09-01 · 2 citations

• Machine Learning-Based Optimization for 5G Resource Allocation Using Classification and Regression Techniques

  International Journal of Computational and Experimental Science and Engineering · 2025-04-24 · 4 citations

• Clinical Safety and Preliminary Efficacy of Regulatory T Cells for ALS

  NEJM Evidence · 2025-04-22 · 13 citations

• Maximizing the Reliability of Machine Learning Based Invasion Detection Systems on a Modern, Unbalanced Dataset

  2025-04-04 · 1 citations

• Non-Invasive Prediction of Vitamin-D Status by Using Machine Learning Algorithm

  2024-12-17

• Molecular and Clinical Determinants of CAR-T Therapy Response in DLBCL

  Blood · 2024-11-05 · 1 citations

• Linking Dental Services to Treatment Outcomes for Diabetes: A Rapid Response Review

  2024-11-01

• Linking Dental Services to Treatment Outcomes for Chronic Kidney Disease: A Rapid Response Review

  2024-11-01

• The Association Between Outcomes and Dental Services in Persons With Autoimmune Disease Treated With Biologics and Other Immunosuppressants: A Rapid Response Review

  2024-11-01

• 748P Phase II dose optimization with EZH2/EZH1 inhibitor tulmimetostat in patients with ARID1A-mutated ovarian clear cell carcinoma

  Annals of Oncology · 2024-09-01 · 1 citations